Glaucoma News

Digital education through CheckedUp interactive screens resulted in better understanding of glaucoma and glaucoma interventions as compared with verbal information, according to a poster presentation at Real World Ophthalmology.

NEW YORK — In this Healio Video Perspective from OSN New York, Susan Benton, president of Thea Pharma, discusses Iyuzeh for primary open-angle glaucoma. The treatment launched during the meeting.

NEW YORK — In this Healio Video Perspective from OSN New York, Nathan M. Radcliffe, MD, discusses reimbursement issues for minimally invasive glaucoma surgery.

When I am performing tests to determine a patient’s glaucoma status — visual fields, retinal nerve fiber layer measurements on OCT, fundus photography, etc — I will also examine their ocular surface and do meibomian gland imaging.

Switching patients to an interventional glaucoma treatment paradigm offers benefits, but ophthalmologists must be aware of how to effectively minimize drawbacks, according to a presentation at Real World Ophthalmology.

Thea Pharma has launched Iyuzeh in the U.S. for the treatment of primary open-angle glaucoma or ocular hypertension.

In refractive and cataract surgery, femtosecond lasers have increased precision and reduced complications.

VIENNA — In this Healio Video Perspective from the ESCRS meeting, Philip Bloom, MD, speaks about endoscopic cyclophotocoagulation for the management of glaucoma.

Iris repair is a technique that I learned in fellowship, and I am often thankful I have this in my skill set.

Approximately 3 million Americans carry the diagnosis of glaucoma. At 5 years after diagnosis, approximately 5% require invasive surgical intervention.